The use of nanobiotechnological elements in the treatment of chronic pain was the focus of the conversation among CEDENNA researchers at the internal seminar held on Thursday, November 26, with Dr. Luis Constandil, who asked whether, after 10 years of designing, synthesizing and testing the efficacy of various nanoparticles for treating chronic pain, it is possible to think about entrepreneurship in this field to spread its benefits. Dr. Constandil explained the reasons why it has been difficult to advance in commercializing this type of element and which paths we should follow in the future to achieve real impact on society.
